Beijing, China

Yabin Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Yabin Li: Innovator in Pharmaceutical Research

Introduction

Yabin Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of three patents to his name, Li's work has the potential to impact various medical conditions.

Latest Patents

One of Yabin Li's latest patents is focused on purine inhibitors of human phosphatidylinositol 3-kinase delta. This invention provides compounds that are PI3K-delta inhibitors, which are useful for treating PI3K-delta-mediated diseases such as inflammation, asthma, COPD, and cancer. The innovative compounds of formula (I) represent a significant advancement in therapeutic options for these conditions.

Career Highlights

Throughout his career, Yabin Li has worked with notable companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Betta Pharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Yabin Li has collaborated with several professionals in his field, including Hua Zhou and Jason David Katz. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Yabin Li is a distinguished inventor whose work in pharmaceutical research has led to valuable patents and advancements in medical treatments. His contributions continue to shape the landscape of drug development and offer hope for patients with various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…